During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.
A structured research culture is central to translating ophthalmic innovation into everyday clinical practice. In a recent ophta interview, Prof. Farhad Hafezi discusses how the ESCRS Research Committee supports collaborative, evidence-based research in corneal, cataract, and refractive surgery, helping align emerging technologies with clinically relevant standards of care across Europe.
Ocular Surgery News interviewed Prof. Farhad Hafezi at ESCRS 2025 on ECO-CAIRS, a technique using ultra high-fluence corneal cross-linking (CXL) to optimize allogenic corneal ring segments before implantation, improving precision and biomechanical stability.
Prof. Farhad Hafezi, MD, PhD, FARVO, has been appointed to the Editorial Board of EuroTimes, the official publication of the European Society of Cataract and Refractive Surgeons (ESCRS). This role further solidifies his contributions to ophthalmic research, education, and innovation.
At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
Intracorneal ring segments (ICRS) can offer significant corneal flattening and vision rehabilitation effects in suitable corneas. This article explores the differences between different ring segments, and the latest advances in ICRS like Femto-CAIRS.
Dual chromophore PACK-CXL treatment using riboflavin/UV-A and rose bengal/green light may offer an effective solution for refractory Acanthamoeba keratitis.
Expert review in Eyenet of corneal cross-linking as an adjunctive treatment for infectious keratitis and corneal melting.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
